Authors

• Dianne Acoba (ORCID: https://orcid.org/0000-0001-9760-9178)
• Peter J. Greasley (ORCID: https://orcid.org/0000-0002-2529-4477)
• Johan Mölne (ORCID: https://orcid.org/0000-0001-6241-7117)
• Annika Wernerson (ORCID: https://orcid.org/0000-0003-2792-0010)
• Anna Levin (ORCID: https://orcid.org/0000-0002-1299-6920)
• Kerstin Ebefors (ORCID: https://orcid.org/0000-0002-6884-183X)
• Jenny Nyström (ORCID: https://orcid.org/0000-0002-2615-8389)
• Anna Witasp (ORCID: https://orcid.org/0000-0002-0827-3586)
• Anna Reznichenko

Institutions

• Inserm (FR)
• Université Paris Cité (FR)
• Karolinska Institutet (SE)
• Institut Necker Enfants Malades (FR)
• AstraZeneca (Sweden) (SE)
• University of Gothenburg (SE)

Publication Details

Journal

BMC Nephrology

Published

2025-08-31

DOI

https://doi.org/10.1186/s12882-025-04364-0

Citations

1

Primary Topic

Chronic Kidney Disease and Diabetes

Type

article

Field-Weighted Citation Impact

1.43

Funders

• European Commission
• Stockholms Läns Landsting
• Horizon 2020